A new multiplex assay detects HIV and hepatitis B, C, and E in a single workflow, improving sensitivity, and efficiency in ...

Shares in Abingdon Health PLC (AIM:ABDX) rose 14% to 8.24p after the AIM-listed rapid diagnostic test developer announced ...

Agena Bioscience, a global provider of molecular genomics solutions, recently announced the launch of the CFTR 100+ Panel, a multiplex genotyping solution designed to provide expanded coverage of CFTR ...

The assay is developed to address current demands of laboratories.

Cloud-Clone drives technological innovation for obesity research, providing validated targets for precise matching of ...

The global immunohistochemistry market is projected to grow at 6.78% CAGR through 2031, supported by increasing cancer prevalence, expanding use of biomarker-based diagnostics, and strong demand ...

The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test, increasing laboratory ...

Cloud-Clone Corp. provides high-quality antibodies, ELISA kits (MAK895Ge21, CEK895Ge, MAV708Ge21, CEV708Ge) to meet the ...

With two decades of dedicated focus in this field, Cloud-Clone has evolved from early-stage exploration into a globally ...

Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...

Semarion has secured new funding to expand its cell-based drug discovery platform, supporting manufacturing scale-up, ...

The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test, increasing laboratory efficiency and decreasing healthcare costs.The new test delivers faster turnaro ...